Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study).

Andrea Chiricozzi,Matteo Megna,Alessandro Giunta, Carlo Giovanni Carrera,Paolo Dapavo,Anna Balato, Piergiorgio Malagoli, Stella Mazzoccoli,Aurora Parodi, Silvia Sabatino, Carlotta Buzzoni, Chu-Han Huang,Alessandra Narcisi

The Journal of dermatological treatment(2023)

引用 0|浏览4
暂无评分
摘要
This 24-month observational cohort study confirmed that ixekizumab is effective in the long-term management of patients with moderate-to-severe plaque psoriasis.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络